Eric Daniel Morris

Dr. Eric Daniel Morris


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2024 in Technical Innovations & Patient Support in Radiation Oncology
Verified
Journal Article
Open access
RBRobbie Beckert
Robbie Beckert
JSJoshua P Schiff
Joshua P Schiff
EMEric Daniel Morris
Eric Daniel Morris
PSPamela Samson
Pamela Samson
HKHyun Kim
Hyun Kim
ELEric Laugeman
Eric Laugeman
• We successfully implemented an APRT for CBCT-guided adaptive contouring. • We hypothesized APRT led contouring would reduce adaptive contouring times. • 183 adaptive sessions were reviewed, 136 APRT led and 47 non-APRT led. • Average APRT led contouring time was 8 min vs. 20 min for non-APRT led. • The APRT statistically significantly improved contouring and total workflow times.

21 July 2023 in Clinical and Translational Radiation Oncology
Verified
Journal Article
Open access
APAlex T. Price
Alex T. Price
JSJoshua P. Schiff
Joshua P. Schiff
ELEric Laugeman
Eric Laugeman
BMBorna Maraghechi
Borna Maraghechi
MSMatthew Schmidt
Matthew Schmidt
LHLauren E. Henke
Lauren E. Henke
Our institution was the first in the world to clinically implement MR-guided adaptive radiotherapy (MRgART) in 2014. In 2021, we installed a CT-guided adaptive radiotherapy (CTgART) unit, becoming one of the first clinics in the world to build a dual-modality ART clinic. Herein we review factors that lead to the development of a high-volume dual-modality ART program and treatment census over an initial, one-year period. The clinical adaptive service at our institution is enabled with both MRgART (MRIdian, ViewRay, Inc, Mountain View, CA) and CTgART (ETHOS, Varian Medical Systems, Palo Alto, CA) platforms. We analyzed patient and treatment information including disease sites treated, radiation dose and fractionation, and treatment times for patients on these two platforms. Additionally, we reviewed our institutional workflow for creating, verifying, and implementing a new adaptive workflow on either platform. From October 2021 to September 2022, 256 patients were treated with adaptive intent at our institution, 186 with MRgART and 70 with CTgART. The majority (106/186) of patients treated with MRgART had pancreatic cancer, and the most common sites treated with CTgART were pelvis (23/70) and abdomen (20/70). 93.0% of treatments on the MRgART platform were stereotactic body radiotherapy (SBRT), whereas only 72.9% of treatments on the CTgART platform were SBRT. Abdominal gated cases were allotted a longer time on the CTgART platform compared to the MRgART platform, whereas pelvic cases were allotted a shorter time on the CTgART platform when compared to the MRgART platform. Our adaptive implementation technique has led to six open clinical trials using MRgART and seven using CTgART. We demonstrate the successful development of a dual platform ART program in our clinic. Ongoing efforts are needed to continue the development and integration of ART across platforms and disease sites to maximize access and evidence for this technique worldwide.

11 August 2023 in Cancers
Verified
Journal Article
Open access
PDF file
EMEric Daniel Morris
Eric Daniel Morris
RCRobert K. Chin
Robert K. Chin
TWTrudy Wu
Trudy Wu
CSClayton Smith
Clayton Smith
SNSiamak P. Nejad-Davarani
Siamak P. Nejad-Davarani
Minsong CaoMinsong Cao
Minsong Cao
There has been a recent effort to treat high-risk ventricular tachycardia (VT) patients through radio-ablation. However, manual segmentation of the VT target is complex and time-consuming. This work introduces ASSET, or Auto-segmentation of the Seventeen SEgments for Tachycardia ablation, to aid in radiation therapy (RT) planning. ASSET was retrospectively applied to CTs for 26 thoracic RT patients (13 undergoing VT ablation). The physician-defined parasternal long-axis of the left ventricle (LV) and the axes generated from principal component analysis (PCA) were compared using mean distance to agreement (MDA) and angle of separation. The manually selected right ventricle insertion point and LVs were used to apply the ASSET model to automatically generate the 17 segments of the LV myocardium (LVM). Physician-defined parasternal long-axis differed from PCA by 1.2 ± 0.3 mm MDA and 6.9 ± 0.7 degrees. Segments differed by 0.69 ± 0.29 mm MDA and 0.89 ± 0.03 Dice similarity coefficient. Running ASSET takes 2 h/patient. Agreement between ASSET and expert contours was comparable to inter-observer variability. Qualitative scoring conducted by three experts revealed automatically generated segmentations were clinically useable as-is. ASSET offers efficient and reliable automatic segmentations for the 17 segments of the LVM for target generation in RT planning.